| 设为主页 | 保存桌面 | 手机版 | 二维码
普通会员

上海惠诚生物科技有限公司

生化试剂、生化仪器、实验耗材及各类标准品、色谱配件等

公司动态
产品分类
联系方式
  • 联系人:文
  • 电话:
  • 邮件:
  • 手机:
站内搜索
 
您当前的位置:首页 » 供应产品 » 甘草次酸 Carbenoxolone
甘草次酸 Carbenoxolone
点击图片查看原图
产品: 浏览次数:490甘草次酸 Carbenoxolone 
品牌: 进口
产品型号: Carbenoxolone 5697-56-3
产品规格: 1g 5g 25g
最小起订量: 1 g
供货总量: 100 g
发货期限: 自买家付款之日起 3 天内发货
有效期至: 长期有效
最后更新: 2023-11-08 09:13
  询价
详细信息
 上海惠诚生物为广大科研用户提供科学仪器,试剂耗材等专业科研产品服务。

代理产品品牌有:Nu-chek、LKT、AccuStandard、APSC、MPBio、Sigma-Aldrich、NIST,Reagecon、Megazyme,LGC、Ultra,日本和光(WAKO)、Shodex,Dr.E、PSS ,Matreya,CaroteNature,瑞典Larodan产品等。提供美国药典USP 、欧洲药典标 EDQM、加拿大TRC标准物质等.

联系人:吕小姐  电话:021-60498804, 13917250134   E-mail:13917250134@163.com  QQ:1715451510

 

Description
Carbenoxolone is a synthetic derivative of the active component of licorice (Glycyrrhiza glabra) and is most well known for its ability to inhibit gap junction connexin channels and 11β-hydroxysteroid dehydrogenase. Carbenoxolone displays a wide variety of beneficial properties, including neuroprotective, anti-inflammatory, and anti-obesity activities. In animal models, carbenoxolone decreases stroke infarction size and neuronal damage after middle cerebral artery occlusion and also delays the onset of experimental autoimmune encephalitis (EAE), potentially by decreasing production of IL-23 and Th17 cells. Carbenoxolone also prevents atrial inflammation and atrial fibrillation by inhibiting macrophage migration into atria. This compound exudes several benefits in obese mice, inhibiting expression of sterol regulatory element binding protein 1c (SREBP1C) and preventing development of fatty liver disease. In vitro, carbenoxolone inhibits expression of pro-inflammatory cytokines and apoptotic proteins; it also prevents fatty acid-induced expression of ROS and reverses fatty acid-induced mitochondrial membrane depolarization. In high-fed diet mice, this compound decreases expression of GLUT4, PPAR-γ, and other lipid-regulating genes, resulting in decreased body weight and visceral fat mass and increased sensitivity to insulin.
Specifications
Cas No. 5697-56-3
Product ID C0167
Product Name Carbenoxolone   甘草次酸、

甘珀酸

Formula C34H50O7   分子式
Formula Wt. 570.76  分子量
Melting Point 292.8ºC
Purity >97%  纯度
References Beraki S, Litrus L, Soriano L, et al. A pharmacological screening approach for discovery of neuroprotective compounds in ischemic stroke. PLoS One. 2013 Jul 18;8(7):e69233. PMID: 23874920.

Okuda H, Nishida K, Higashi Y, et al. NAD(+) influx through connexin hemichannels prevents poly(ADP-ribose) polymerase-mediated astrocyte death. Life Sci. 2013 Apr 19;92(13):808-14. PMID: 23454167.

Oishi S, Sasano T, Tateishi Y, et al. Stretch of atrial myocytes stimulates recruitment of macrophages via ATP released through gap-junction channels. J Pharmacol Sci. 2012;120(4):296-304. PMID: 23196902.

Rhee SD, Kim CH, Park JS, et al. Carbenoxolone prevents the development of fatty liver in C57BL/6-Lep ob/ob mice via the inhibition of sterol regulatory element binding protein-1c activity and apoptosis. Eur J Pharmacol. 2012 Sep 15;691(1-3):9-18. PMID: 22742899.

Sano S, Nakagawa Y, Yamaguchi R, et al. Carbenoxolone alters the morphology of adipose tissues and downregulates genes involved in adipogenesis, glucose transport and lipid metabolism in high-fat diet-fed mice. Horm metab Res. 2012 Jan;44(1):15-20. PMID: 22205568.

Endong L, Shijie J, Sonobe Y, et al. The gap-junction inhibitor carbenoxolone suppresses the differentiation of Th17 cells through inhibition of IL-23 expression in antigen presenting cells. J Neuroimmunol. 2011 Dec 15;240-241:58-64. PMID: 22036952.
询价单